reproductive
Introduction to Medications Related to the Reproductive and Genitourinary (GU) Systems
Teaching focus: Medications related to the reproductive system and the GU system.
Teaching style: Information tailored to exam requirements.
Audience understanding: Not everything is critical; some points are basic knowledge, others are essential.
Disclaimers Regarding Terminology
Usage of the terms "male" and "female":
Refers to biological sex rather than gender identity during the lecture.
Emphasis on patients assigned male at birth (AMAB) and patients assigned female at birth (AFAB).
Overview of the Reproductive and GU Systems
The reproductive system involves structures related to reproduction in both sexes:
Primary and secondary sexual characteristics.
The GU system is connected to urination and involves:
Genital organs and urinary system.
The Male Reproductive System
Structures of the male reproductive system:
Testes/testicles: Responsible for sperm production.
Scrotum: Housing for the testes; regulates temperature.
Bladder: Located above the testes.
Vas deferens: Transports sperm.
Prostate: Unique to males, women assigned female at birth do not have this structure.
Penis: Part of both urinary and reproductive systems.
Urethra: Pathway for urination and ejaculation.
Seminal vesicles: Contribute fluid for sperm nourishment.
Function of the male reproductive system:
Supports sexual maturation and sperm production, storage, and ejaculation.
Testicular Health and Function
Optimal conditions for testes:
Testes should descend outside the abdominal cavity for temperature regulation: colder temperatures cause the scrotum to raise, warmer temperatures cause relaxation.
Spermatogenesis:
The process of sperm production occurs over approximately 2.5 to 3 months (about 60 to 70 days).
Each ejaculation can produce approximately 2 to 8 milliliters of semen containing 100 million to 200 million sperm.
Issues affecting sperm quality:
Low sperm count or immobility can indicate health problems.
Abnormalities such as missing heads on sperm can occur.
The Prostate
Location and Role:
Surrounds the urethra and contributes fluids to semen.
Prostate issues can lead to urinary symptoms due to urethral obstruction.
Hormonal Regulation in Males
Hormones involved in the male reproductive system:
Follicle Stimulating Hormone (FSH): Initiates sperm production.
Luteinizing Hormone (LH): Stimulates testosterone production, vital for sperm maturation.
Impact of testosterone:
Development of secondary sexual characteristics: hair distribution, deeper voice, muscle mass.
Responsible for potential virilization effects in females taking testosterone.
Testosterone as Medication
Indications for testosterone therapy:
Hypogonadism: Low testosterone production.
Delayed puberty.
Testicular failure.
Use in breast cancer treatment to counter estrogen.
Monitoring while on testosterone:
Regular checks of hemoglobin (H) and hematocrit (Hct).
High levels increase blood viscosity, leading to clotting risk and strokes.
Disorders of the Prostate
Benign Prostatic Hyperplasia (BPH):
Non-cancerous enlargement of prostate tissue leads to urethral obstruction.
Common symptoms include:
Nocturia: Increased urination during night.
Urinary frequency and hesitancy.
Weak urine stream or dribbling.
Recurrent bladder infections due to incomplete emptying.
Significance of prostate size:
Enlarged prostate can lead to increase pressure on bladder and kidneys, causing issues like kidney damage if untreated.
Medications for BPH
5-alpha reductase inhibitors:
Example: Finasteride (Proscar).
Mechanism: Reduces testosterone levels in the prostate.
Side effects: Reduced libido, gynecomastia, ejaculate volume decrease.
Alpha-adrenergic receptor antagonists:
Example: Tamsulosin (Flomax).
Mechanism: Relaxes smooth muscle in prostate, aiding urine flow.
Monitoring: Be aware of potential hypotension, especially when combined with PDE5 inhibitors like Viagra.
Erectile Dysfunction (ED)
Definition:
Inability to achieve or maintain an erection sufficient for satisfactory intercourse (subjective).
Causes of ED:
Psychogenic factors: performance anxiety, relationship issues.
Organic factors:
Neurogenic causes from nerve issues.
Hormonal (low testosterone).
Cardiovascular problems affecting blood flow.
Drug-induced causes, including side effects from antidepressants, antihypertensives, or recreational drugs.
Diagnosis methods:
History-taking, determining medication impacts, and assessing vascular risk factors.
Treatment Options for ED
PDE5 inhibitors (e.g., Sildenafil/Viagra):
Mechanism: Smooth muscle relaxation increases blood flow to the penis.
Risks: Hypotension, potentially dangerous if taken with nitroglycerin.
Contraindications: Must be aware of existing heart conditions.
The Urinary Tract Anatomy and Function
Renal Anatomy:
Kidneys filter approximately 120 to 150 milliliters of blood to produce urine.
Structure includes:
Kidneys
Ureters
Bladder
Urethra: Men’s urethra is longer than women’s.
Common urinary issues:
Urinary Tract Infections (UTIs): More common in women due to shorter urethra.
Risk factors include increased sexual activity, menopause, urinary retention, etc.
UTI Symptoms and Treatments
Signs of UTI include urinary frequency, urgency, and dysuria.
Treatments:
Phenazopyridine: Local anesthetic for bladder pain (can turn urine orange).
Antibiotics: Nitrofurantoin for uncomplicated UTIs, ciprofloxacin for more severe cases.
Final Notes
Patients on antibiotics and phenazopyridine may get frequent UTIs; it is essential to finish the full course of antibiotics to reduce recurrence risk.